Development Update on CyclASol® Topical Ophthalmic Solution for the Treatment of Dry Eye Disease
Heidelberg – July 23, 2020 – Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, today provided a development update on its investigational water-free and preservative-free drug CyclASol®.